Consonance Capital Management LP Deciphera Pharmaceuticals, Inc. Transaction History

Consonance Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $10.3 Million - $14.4 Million	-388,222 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $19.8 Million - $29 Million	-605,690 Reduced 60.94%	388,222 $14.2 Million
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $20.6 Million - $28.9 Million	509,241 Added 105.07%	993,912 $44.6 Million
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $25.1 Million - $32.1 Million	484,671 New	484,671 $27.7 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.